Bg pattern

ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Abacavir/Lamivudine Glenmark 600 mg/300 mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

IMPORTANT — Hypersensitivity Reactions

Abacavir/Lamivudine Glenmark contains abacavir(which is also an active substance in medicines such as Trizivir,Triumeqand Ziagen). Some people who take abacavir may develop a hypersensitivity reaction(a severe allergic reaction), which can be life-threatening if they continue to take medicines containing abacavir.

You must read the information about “Hypersensitivity reactions” in section 4 of this leaflet carefully.

The packaging of Abacavir/Lamivudina Glenmark includes an Information Cardto remind you and your healthcare provider of abacavir hypersensitivity. You must take out this card and always carry it with you.

Contents of the pack and other information

  1. What is Abacavir/Lamivudina Glenmark and what is it used for
  2. What you need to know before you take Abacavir/Lamivudina Glenmark
  3. How to take Abacavir/Lamivudina Glenmark
  4. Possible side effects
  5. Storing Abacavir/Lamivudina Glenmark

Contents of the pack and other information

1. What is Abacavir/Lamivudina Glenmark and what is it used for

Abacavir/lamivudine is used to treat HIV infection in adults, adolescents, and children who weigh at least 25 kg.

Abacavir/lamivudine contains two active substances used to treat HIV infection: abacavir and lamivudine. Both belong to a group of antiretroviral medicines called nucleoside analogue reverse transcriptase inhibitors(NRTIs).

Abacavir/lamivudine does not completely cure HIV infection; it reduces the amount of virus in the body and keeps it at a low level. It also increases the number of CD4 cells in the blood. CD4 cells are a type of white blood cell that helps your body fight infection.

Not everyone responds to treatment with abacavir/lamivudine in the same way. Your doctor will monitor the effectiveness of your treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Abacavir/Lamivudina Glenmark

Do not take Abacavir/Lamivudina Glenmark

  • if you are allergic(hypersensitive)to abacavir (or to any other medicine that contains abacavir (e.g. Trizivir,Triumeqor Ziagen), lamivudine, or to any of the other ingredients of this medicine (listed in section 6). Read the information about hypersensitivity reactions in section 4 of this leaflet carefully.
  • Consult your doctorif you think any of these apply to you. Do not take Abacavir/Lamivudina Glenmark

Be especially careful with Abacavir/Lamivudina Glenmark

Some people who take Abacavir/Lamivudina or other combination treatments for HIV have a higher risk of serious side effects. You need to know that there is a higher risk:

  • if you have moderate or severe liver disease.
  • if you have ever had liver disease, including hepatitis B or C (if you have hepatitis B, do not stop taking Abacavir/Lamivudina Glenmark without your doctor's advice, as it may get worse)
  • if you are significantly overweight(especially if you are a woman)
  • if you have kidney problems.

Consult your doctor before taking Abacavir/Lamivudina Glenmark if you have any of these conditions.You may need to have additional tests, including blood tests, while taking this medicine. See section 4 for more information.

Hypersensitivity reactions to Abacavir

Even patients who do not have the HLA-B*5701 gene may develop a hypersensitivity reaction(a severe allergic reaction).

Read the information about hypersensitivity reactions in section 4 of this leaflet carefully.

Risk of cardiovascular events

It cannot be excluded that abacavir increases the risk of cardiovascular events.

Tell your doctorif you have cardiovascular problems, smoke, or suffer from diseases that may increase your risk of cardiovascular diseases, such as high blood pressure and diabetes. Do not stop taking this medicine unless your doctor advises you to.

Be aware of important symptoms

Some people who take medicines for HIV infection develop other conditions, which can be serious. You need to know what important signs and symptoms to look out for while taking Abacavir/Lamivudina Glenmark.

Read the information about “Other possible side effects of combination antiretroviral therapy” in section 4 of this leaflet.

Other medicines and Abacavir/Lamivudina Glenmark

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines,including herbal medicines and those bought without a prescription.

Remember to tell your doctor or pharmacist if you start taking a new medicine while taking Abacavir/Lamivudina Glenmark.

The following medicines must not be used with Abacavir/Lamivudina Glenmark:

  • Emtricitabine, to treat HIV infection
  • Other medicines that contain lamivudine, used to treat HIV infection or hepatitis B
  • High doses of trimethoprim/sulfamethoxazole, an antibiotic
  • Cladribine, used to treat hairy cell leukemia.

Tell your doctorif you are being treated with any of these medicines.

Some medicines interact with Abacavir/Lamivudina Glenmark

These include:

  • Phenytoin, to treat epilepsy. Tell your doctorif you are taking phenytoin. Your doctor may need to monitor you while you are taking Abacavir/Lamivudina Glenmark.
  • Methadone, used as a heroin substitute. Abacavir increases the rate at which methadone is removed from the body. If you are taking methadone, you may need to be monitored for signs of withdrawal. You may need to have your methadone dose changed. Tell your doctorif you are taking methadone.
  • Medicines (usually liquids) that contain sorbitol and other polyalcohols(such as xylitol, mannitol, lactitol, or maltitol), if taken regularly.

Tell your doctor or pharmacistif you are being treated with any of these.

  • Riociguat, to treat high blood pressure in the blood vessels (arteries) that carry blood from the heart to the lungs. Your doctor may need to reduce your dose of riociguat, as abacavir may increase the levels of riociguat in your blood.

Pregnancy

Abacavir/Lamivudina Glenmark is not recommended during pregnancy.Abacavir/Lamivudina and similar medicines may cause side effects in the fetus during pregnancy.

If you have been taking Abacavir/lamivudine during your pregnancy, your doctor may ask for regular blood tests and other diagnostic tests to monitor the development of your child. In children whose mothers took NRTIs during pregnancy, the benefit of protection against HIV was greater than the risk of side effects.

Breast-feeding

It is recommended that HIV-infected women do not breast-feed their babies because HIV infection can be passed to the baby through breast milk. A small amount of the components of Abacavir/Lamivudina Glenmark may also pass into breast milk.

If you are breast-feeding or think you may want to, consult your doctor as soon as possible.

Driving and using machines

Abacavir/Lamivudina Glenmark may cause side effects that can affect your ability to drive or use machines. Consult your doctorabout your ability to drive or use machines while taking this medicine.

Important information about some of the ingredients of Abacavir/Lamivudina Glenmark.

This medicine contains a colorant called orange yellow (E110), which may cause allergic reactions in some people.

3. How to take Abacavir/Lamivudina Glenmark

Always take this medicine exactly as your doctor has told you.

If you are not sure, consult your doctor or pharmacist.

The recommended dose of abacavir/lamivudine for adults, adolescents, and children who weigh at least 25 kg or more is one tablet once a day.

Swallow the tablets whole, with a little water. Abacavir/lamivudine can be taken with or without food.

Stay in regular contact with your doctor.

Abacavir/lamivudine helps to control your condition. You need to take it every day to control your HIV infection. You may still develop other infections and illnesses associated with HIV.

Stay in touch with your doctor and do not stop taking abacavir/lamivudinawithout discussing it with your doctor first.

If you take more Abacavir/Lamivudina Glenmark than you should

If you accidentally take more abacavir/lamivudine than you should, tell your doctor or pharmacist, or contact the emergency department of your nearest hospital for more information.

If you forget to take Abacavir/Lamivudina Glenmark

If you forget to take a dose, take it as soon as you remember and then continue with your normal treatment schedule.

Do not take a double dose to make up for a forgotten dose.

It is important to take abacavir/lamivudine regularly, as irregular intake of abacavir/lamivudine can increase the risk of a hypersensitivity reaction.

If you have stopped taking Abacavir/Lamivudina Glenmark

If, for any reason, you have stopped taking abacavir/lamivudine, especially because you think you have had side effects or because of another illness:

Consult your doctor before restarting treatment.Your doctor will check whether your symptoms were related to a hypersensitivity reaction. If your doctor thinks that they were, you should never take abacavir/lamivudina or any other medicine that contains abacavir(e.g. Trizivir,Triumeqor Ziagen) again.It is important that you follow this advice.

If your doctor advises you to restart treatment with abacavir/lamivudine, they may ask you to take the first doses in a place where you can easily get medical help if you need it.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

During HIV treatment, there may be an increase in weight and blood glucose and lipid levels. This may be partly related to health recovery and lifestyle, and in the case of blood lipids, sometimes to HIV medications themselves. Your doctor will monitor these changes.

Like all medications, this medication can cause adverse effects, although not all people will experience them.

When undergoing HIV treatment, it can be difficult to distinguish whether a symptom is an adverse effect of Abacavir/Lamivudina Glenmark or other medications being taken, or is due to an effect of the HIV disease itself. Therefore, it is very important that you inform your doctor aboutany change in your health.

Even patients who do not have the HLA-B*5701 gene can develop a hypersensitivity reaction(a severe allergic reaction), described in this prospectus in the section called "Hypersensitivity Reactions".

It is very important that you read and understand the information about this severe reaction.

In addition to the adverse effects listed below for this medication, other disorders can develop during combined HIV treatment.

It is important that you read the information under the heading “Other possible adverse effects of combined HIV treatment”.

Hypersensitivity Reactions

Abacavir/LamivudinaGlenmarkcontains abacavir(an active ingredient also present in Trizivir, Triumeqand Ziagen).

Abacavir can cause a severe allergic reaction known as a hypersensitivity reaction. These hypersensitivity reactions have been observed more frequently in people taking medications containing abacavir.

Who suffers from these reactions?

Anyone taking Abacavir/Lamivudina Glenmark could develop a hypersensitivity reaction to abacavir, which could put their life at risk if they continue taking Abacavir/Lamivudina Glenmark.

You are more likely to develop this reaction if you have a gene called HLA-B*5701(but you can suffer from this reaction even if you do not have this gene). Before starting treatment with Abacavir/Lamivudina Glenmark, you should have been tested for this gene. If you know you have this gene, tell yourdoctor before taking Abacavir/Lamivudina Glenmark.

About 3 to 4 out of every 100 patients treated with abacavir in a clinical trial who did not have the HLA-B*5701 gene developed a hypersensitivity reaction.

What are the symptoms?

The most frequent symptoms are:

  • fever(high temperature) and skin rash.

Other frequently observed signs are:

  • nausea (discomfort), vomiting, diarrhea, abdominal pain (stomach) and excessive fatigue.

Other symptoms may include:

  • pain in the joints or muscles, swelling of the neck, difficulty breathing, sore throat, cough and occasional headache, eye inflammation (conjunctivitis), mouth ulcers and low blood pressure and, tingling or numbness of the hands or feet.

When do these reactions occur?

Hypersensitivity reactions can appear at any time during treatment with Abacavir/Lamivudina Glenmark, but are more likely to occur in the first 6 weeks of treatment.

Contact your doctor immediately:

  • fever
  • difficulty breathing, sore throat or cough
  • nausea or vomiting, diarrhea or abdominal pain
  • excessive fatigue or pain or general discomfort.

Your doctor may advise you to stop taking Abacavir/Lamivudina Glenmark.

If you have stopped taking Abacavir/Lamivudina Glenmark.

If you have stopped taking Abacavir/Lamivudina Glenmark due to a hypersensitivity reaction, NEVER AGAINtake Abacavir/Lamivudina Glenmark or any other medication containing abacavir (e.g. Trizivir, Triumeq or Ziagen). If you do, within hours, you may experience a drop in blood pressure that can pose a risk to your life or cause death.

If, for any reason, you have interrupted treatment with Abacavir/Lamivudina Glenmark—especially because you think you have adverse effects or due to another illness:

Consult your doctor before restarting treatment. Your doctor will check if your symptoms were related to a hypersensitivity reaction. If your doctor considers that there may have been a relationship, they will indicate that you should never again take Abacavir/Lamivudina Glenmark or any othermedication containing abacavir(e.g. Trizivir, Triumeq or Ziagen).It is important that you follow this warning.

Occasionally, hypersensitivity reactions have developed in people who restart abacavir after having had only one symptom of those included in the Information Card before stopping it.

Very rarely, reactions have developed in people who restart treatment with abacavir but had no symptoms of hypersensitivity before stopping it.

If your doctor advises you to restart treatment with Abacavir/Lamivudina Glenmark, they may ask you to take the first doses in a place where you have easy access to medical assistance if necessary.

If you are hypersensitive to Abacavir/Lamivudina, you must return all your unused Abacavir/Lamivudina Glenmark tablets to be safely disposed of.Consult your doctor or pharmacist.

The packaging of Abacavir/Lamivudina Glenmark includes an Information Card to remind you and healthcare personnel about hypersensitivity reactions. Separate the card from the packaging and always carry it with you.

Frequent Adverse Effects

May affect up to 1 in 10patients:

  • hypersensitivity reaction
  • headache
  • vomiting
  • discomfort (nausea)
  • diarrhea
  • stomach pain
  • loss of appetite
  • fatigue, lack of energy
  • fever (high temperature)
  • general feeling of discomfort
  • difficulty sleeping (insomnia)
  • muscle pain and discomfort
  • joint pain
  • cough
  • irritated or runny nose
  • skin rash
  • hair loss.

Uncommon Adverse Effects

May affect up to 1 in 100patients and may be reflected in blood tests:

  • low red blood cell count (anemia) or low white blood cell count (neutropenia)
  • increased levels of liver enzymes
  • a decrease in the number of cells involved in blood clotting (thrombocytopenia).

Rare Adverse Effects

May affect up to 1 in 1,000patients:

  • liver disorders, such as jaundice, liver enlargement or fatty liver, inflammation (hepatitis)
  • pancreas inflammation (pancreatitis)
  • muscle tissue rupture

The rare adverse effects that may appear in blood tests are:

  • increased levels of an enzyme called amylase.

Very Rare Adverse Effects

May affect up to 1 in 10,000patients:

  • numbness, tingling sensation in the skin (pinpricks)
  • sensation of weakness in the limbs
  • skin rash that can form blisters resembling small targets (dark central spot surrounded by a paler area, with a dark ring around the edge) (erythema multiforme)
  • widespread rash with blisters and skin peeling, especially around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form that causes skin peeling on more than 30% of the body surface (toxic epidermal necrolysis).

If you notice any of these symptoms, contact a doctor urgently.

A very rare adverse effect that may appear in blood tests is:

  • failure of the bone marrow to produce new red blood cells (pure red cell aplasia).

If you experience adverse effects

Tell your doctor or pharmacistif you consider that any of the adverse effects you are experiencing is serious or if you notice any adverse effect not mentioned in this prospectus.

Other possible adverse effects of combined HIV treatment

Combined treatments, such as Abacavir/Lamivudina, can cause other disorders to develop during HIV treatment.

Infection and inflammation symptoms

Exacerbation of old infections

People with advanced HIV infection (AIDS) have a weakened immune system and are more likely to develop severe infections (opportunistic infections). Such infections may have been "latent" and not detected by the weakened immune system before starting treatment. After starting treatment, the immune system becomes stronger, so it begins to fight these infections, which can cause symptoms of infection or inflammation. The symptoms usually include fever, in addition to some of the following:

  • headache
  • stomach pain
  • difficulty breathing

In rare cases, as the immune system becomes stronger, it can also attack healthy tissues (autoimmune disorders). The symptoms of autoimmune disorders can appear many months after starting to take medications to treat HIV infection. The symptoms can include:

  • palpitations (rapid or irregular heartbeats) or tremors
  • hyperactivity (excessive restlessness and movement)
  • weakness that starts in the hands and feet and moves up to the torso.

If you observe any symptoms of infectionand inflammation or if you notice any of the above symptoms:

Tell your doctor immediately. Do not take any other medication for the infection without your doctor's advice.

You may have bone problems

Some patients receiving combined HIV treatment develop a bone disease called osteonecrosis. In this disease, part of the bone tissue dies due to a reduction in blood supply to the bone. People are more likely to suffer from this disease:

  • if they have been taking combined treatment for a long time
  • if they also take anti-inflammatory medications called corticosteroids
  • if they drink alcohol
  • if their immune system is severely weakened
  • if they are overweight

The signs of osteonecrosis include:

  • stiffness in the joints
  • pain and discomfort (especially in the hip, knee or shoulder)
  • difficulty moving

If you notice any of these symptoms:

Tell your doctor.

Reporting adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Abacavir/Lamivudina Glenmark

Keep this medication out of sight and reach of children.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Store below 25 °C.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. This will help protect the environment.

6. Package contents and additional information

Composition of Abacavir/Lamivudina Glenmark

  • The active ingredients of this medication are 600 mg of abacavir and 300 mg of lamivudine.
  • The other components are: microcrystalline cellulose, crospovidone, povidone, yellow iron oxide (E172) and magnesium stearate in the tablet core. The tablet coating contains: hypromelose, titanium dioxide (E171), macrogol, polysorbate 80 and orange-yellow lake FCF (E110).

Appearance of the product and package contents

Abacavir/Lamivudina Glenmark film-coated tablets are film-coated tablets with a modified capsule shape, orange in color and biconvex. The tablet dimensions are 20.6 mm x 9.1 mm, with a “300” engraved on one face and a “600” on the other face.

This medication is available in packages containing 30, 60 or 90 tablets, in unit dose blisters in packages containing 30 x 1 or 90 x 1 film-coated tablets or in multiple packages containing 60 or 90 film-coated tablets.

The 30-tablet bottles contain an activated carbon and oxygen absorbent packet for humidity control in the bottle.

Not all package sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Glenmark Arzneimittel GmbH

Industriestr. 31

82194 Gröbenzell

Germany

Manufacturer:

Glenmark Pharmaceuticals s.r.o.

Fibíchova 143

566 17 Vysoké Mýto

Czech Republic

Pharmadox Healthcare Ltd

KW20A Kordin Industrial Estate Paola

PLA 3000

Malta

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Glenmark Farmacéutica, S.L.U.

C/ Retama 7, 7ª planta

28045 Madrid

Spain

This medication is authorized in EEA member states with the following names:

Country

Name

Germany

Abacavir/Lamivudin Glenmark 600 mg/300 mg Filmtabletten

Denmark

Abacavir/Lamivudine Glenmark 600 mg/300 mg filmovertrukne tabletter

Spain

Abacavir/Lamivudina Glenmark 600 mg/300 mg comprimidos recubiertos con película EFG

Netherlands

Abacavir/Lamivudine Glenmark 600 mg/300 mg film-coated tablets

Sweden

Abacavir/Lamivudine Glenmark 600 mg/300 mg fimdragerade tabletter

Date of the last revision of this prospectus:April 2023.

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS

Discuss questions about ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Lizaveta Trafimchuk Takhvaniuk

Dermatology 10 years exp.

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Camera Book a video appointment
€68
5.0 (1164)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€87
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (191)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€60
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55

Get ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS?
ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS?
The active ingredient in ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS is lamivudine and abacavir. This information helps identify medicines with the same composition but different brand names.
Who manufactures ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS?
ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS is manufactured by Glenmark Arzneimittel Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ABACAVIR/LAMIVUDINE GLENMARK 600 mg/300 mg FILM-COATED TABLETS?
Other medicines with the same active substance (lamivudine and abacavir) include ABACAVIR/LAMIVUDINE AUROVITAS 600 mg/300 mg FILM-COATED TABLETS, ABACAVIR/LAMIVUDINE Dr. Reddy's 600 mg/300 mg FILM-COATED TABLETS, ABACAVIR/LAMIVUDINE KERN PHARMA 600 mg/300 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media